Top

Published in:

01-05-2006

From Corrections to Communities as an HIV Priority

Authors: David Vlahov, PhD, Sara Putnam

Published in: Journal of Urban Health | Issue 3/2006

Excerpt

The health of inmates in correctional facilities has been a longstanding concern in the medical community1 and historically has centered on the health of populations entering correctional settings, which may affect the risk of infectious disease transmission inside these facilities.2,3 Recently, however, more attention has been devoted to public health consequences of inmates released to the community, where continuity of care represents a challenge for treatment and prevention, and there is an increasing appreciation of inmates being part of the public health in the community to which they are released.4,5 In 1983, the first case of AIDS was reported from a prison in the United States.6 Since that time, nearly 5% of the HIV/AIDS cases in the U.S. have been reported from correctional facilities, although the census for these facilities account for less than 1% of the population.6 This disproportionate representation of AIDS cases has garnered attention, and AIDS in the correctional setting over the past two decades provides an illustration of the changing and evolving perspectives on health in corrections facilities and also highlights areas where improvements in knowledge and intervention efforts can be made. …

Derro RA. Health problems in a city-county workhouse. Public Health Rep. 1978;93:379–385.PubMed

Niveau G. Prevention of infectious disease transmission in correctional settings: a review. Public Health. 2006;120(1):33–41.PubMedCrossRef

Weinbaum CM, Sabin KM, Santibanez SS. Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS. 2005;19(Suppl 3):S41–S46.PubMedCrossRef

Springer SA, Altice FL. Managing HIV/AIDS in correctional settings. Curr HIV/AIDS Rep. 2005;2:165–170.PubMedCrossRef

Freudenberg N. Jails, prisons, and the health of urban populations: a review of the impact of the correctional system on community health. J Urban Health. 2001;78:214–235.PubMed

Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from U.S. correctional facilities, 1997. Am J Public Health. 2002;92(11):1789–1794.PubMed

Decker MD, Vaughn WK, Brodie JS, et al. Seroepidemiology of hepatitis B in Tennessee prisoners. J Infect Dis. 1984;150:450–459.PubMed

Anda RF, Perlman SB, D'Alessio DJ, Davis JP, Dodson VN. Hepatitis B in Wisconsin male prisoners: considerations for serologic screening and vaccination. Am J Public Health. 1985;75(10):1182–1185.PubMed

Hull HF, Lyons LH, Mann JM, Hadler SC, Steece R, Skeels MR. Incidence of hepatitis B in the penitentiary of New Mexico. Am J Public Health. 1985;75(10):1213–1214.PubMed

10.

Miller N, Moses L, eds. Confronting AIDS. Washington, DC: National Academy Press, 1990.

11.

Kinsey AC, Pomeroy WR, Martin CE. Sexual behavior in the human male, 1948. Am J Public Health. 2003;93(6):894–898.PubMed

12.

Vlahov D, Brewer TF, Munoz A, et al. Temporal trends of human immunodeficiency virus type-1 (HIV 1) infection among inmates entering a statewide prison system, 1985–1987. J Aquir Immune Defic Syndr. 1989;2:283–290.

13.

Des Jarlais DC, Friedman SR. HIV epidemiology and interventions among injecting drug users. Int J STD AIDS. 1996;7(Suppl 2):57–61.PubMedCrossRef

14.

Vlahov D, Munoz A, Brewer F, Taylor E, Canner C, Polk BF. Seasonal and annual variation of antibody to HIV-1 among male inmates entering Maryland prisons: update. AIDS. 1990;4:345–350.PubMedCrossRef

15.

Behrendt C, Kendig N, Dambita C, Horman J, Lawlor J, Vlahov D. Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. Am J Epidemiol. 1994;139:918–926.PubMed

16.

Kassira EN, Bauserman RL, Tomoyasu N, Cladeira E, Swetz A, Solomon L. HIV and AIDS surveillance among inmates in Maryland prisons. J Urban Health. 2001;78:256–263.PubMed

17.

Solomon L, Flynn C, Muck K, Vertefeuille J. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health. 2004;81:21–37.

18.

Vlahov D, Brewer TF, Castro KG, Narkunas JP, Salive ME, Ullrich J, Munoz A. Prevalence of antibody to HIV-1 among entrants to U.S. correctional facilities. JAMA. 1991;265:1129–1132.PubMedCrossRef

19.

Glass GE, Hausler WJ, Loeffelholz PL, Yesalis CE 3rd. Seroprevalence of HIV antibody among individuals entering the Iowa Prison System. Am J Public Health. 1988;78:447–919.PubMed

20.

Weisfuse IB, Greenberg BL, Back SD, Makki, et al. HIV-1 infection among New York City inmates. AIDS. 1991;5:1133–1138.PubMedCrossRef

21.

Smith PF, Mikl J, Truman BI, et al. HIV infection among women entering the New York State correctional system. Am J Public Health. 1991;81(Suppl):35–40.PubMed

22.

Rich JD, Dickinson BP, Macalino G, et al. Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island. J Acquir Immune Defic Syndr. 1999;22:161–166.PubMed

23.

Altice FL, Mostashari F, Selwyn PA, et al. Predictors of HIV infection among newly sentenced male prisoners. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:444–453.PubMed

24.

Wu ZH, Baillargeon J, Grady JJ, Black SA, Dunn K. HIV seroprevalence among newly incarcerated inmates in the Texas correctional system. Ann Epidemiol. 2001;11:342–346.PubMedCrossRef

25.

Hoxie NJ, Chen MH, Prieve A, Haase B, Pfister J, Vergeront JM. HIV seroprevalence among male prison inmates in the Wisconsin Correctional System. WMJ. 1998;97(5):28–31.PubMed

26.

Takashima HT, Cruess DF, McDonald KR, Duggirala S, Gaydos JC. Tuberculosis and HIV infection in new inmates in Federal Bureau of Prisons facilities. Mil Med. 1996;161(5):265–267.PubMed

27.

Ruiz JD, Molitor F, Plagenhoef JA. Trends in hepatitis C and HIV infection among inmates entering prisons in California, 1994 versus 1999. AIDS. 2002;16:2236–2238.PubMedCrossRef

28.

Kim AA, McFarland W, Kellogg T, Katz MH. Sentinel surveillance for HIV infection and risk behavior among adolescents entering juvenile detention in San Francisco: 1990–1995. AIDS. 1999;20:1597–1598.CrossRef

29.

Carpenter CL, Longshore D, Annon K, Annon JJ, Anglin MD. Prevalence of HIV-1 among recent arrestees in Los Angeles County, California: serial cross-sectional study, 1991–1995. J Acquir Immune Defic Syndr. 1999;21:172–177.PubMed

30.

Sabin KM, Frey RL Jr, Horsley R, Greby SM. Characteristics and trends of newly identified HIV infections among incarcerated populations: CDC HIV voluntary counseling, testing, and referral system, 1992–1998. J Urban Health. 2001;78:241–255.PubMed

31.

Nacci PL, Kane TR. Sex and sexual aggression in federal prisons. Federal Prison System, U.S. Department of Justice. Prog Rep. 1982;1:7–12.

32.

Robertson JE. Rape among incarcerated men: sex, coercion and STDs. AIDS Patient Care STDS. 2003;17:423–430.PubMedCrossRef

33.

Wohl AR, Johnson D, Jordan W, et al. High-risk behaviors during incarceration in African-American men treated for HIV at three Los Angeles public medical centers. J Acquir Immune Defic Syndr. 2000;24:386–392.PubMed

34.

Clarke JG, Stein MD, Hanna L, Sobota M, Rich JD. Active and former injection drug users report of HIV risk behaviors during periods of incarceration. Subst Abus. 2001 Dec;22(4):209–216.PubMedCrossRef

35.

Historical summary of sentencing and punishment in Florida: 1980 to 1999. Tallahassee, Florida: Department of Corrections, 1999.

36.

Vlahov D, Polk BF. Intravenous drug use and human immunodeficiency virus infection in prison. AIDS Publ Policy J. 1988;3:42–46.

37.

Kelly PW, Redfield RR, Ward DL. Prevalence and incidence of HTLV-III infection in a prison. JAMA. 1986;256:2198–2199.CrossRef

38.

Horsburgh CR Jr, Jarvis JQ, MacArthur T, et al. Seroconversion to human immunodeficiency virus infection in prison inmates. Am J Public Health. 1990;80:209–210.PubMed

39.

Brewer TF, Vlahov D, Taylor E, et al. Transmission of HIV-1 within a statewide prison system. AIDS. 1988;2:363–367.PubMedCrossRef

40.

Macalino GE, Vlahov D, Sanford-Colby S, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004;94:1218–1223.PubMed

41.

Mutter RC, Grimes RM, Labrathe D. Evidence of intraprison spread of HIV infection. Arch Intern Med. 1994;154:793–795.PubMedCrossRef

42.

Taylor A, Goldberg D, Emslie J, et al. Outbreak of HIV infection in a Scottish prison. BMJ. 1995;310(6975):289–292.PubMed

43.

Gore SM, Bird AG. HIV transmission in jail. BMJ. 307:147–148.

44.

Choopanya K, Des Jarlais DC, Vanichseni S, et al. Incarceration and risk for HIV infection among injection drug users in Bangkok. J Acquir Immune Defic Syndr. 2002;29:86–94.PubMed

45.

Centers for Disease Control and Prevention. HIV/AIDS education and prevention programs for adults in prisons and jails and juveniles in confinement facilities—United States. JAMA. 1996;275:1306–1308.CrossRef

46.

Braithwaite RL, Arriola KR. Male prisoners and HIV prevention: a call for action ignored. Am J Public Health. 2003;93:759–763.PubMed

47.

Belenko S, Shedlin M, Chaple M. HIV risk behaviors, knowledge and prevention service experiences among African American and other offenders. J Health Care Poor Underserved. 2005;16(4 Suppl B):108–127.PubMedCrossRef

48.

Harding TW. AIDS in prison. Lancet. 1987;2(8570):1260–1263.PubMedCrossRef

49.

Andrus JK, Fleming DW, Knox C, et al. HIV testing in prisoners: is mandatory testing mandatory? Am J Public Health. 1989;79:8400–8402.

50.

Hoxie NJ, Vergeront JM, Frisby HR, Pfister JR, Golubjatnikov R, Davis JP. HIV seroprevalence and the acceptance of voluntary HIV testing among newly incarcerated male prison inmates in Wisconsin. Am J Public Health. 1990;80:1129–11231.PubMedCrossRef

51.

Weinbaum C, Lyerla R, Margolis HS, Centers for Disease Control and Prevention. Prevention and control of infections with hepatitis viruses in correctional settings. MMWR Recomm Rep. 2003;52(RR-1):1–36.PubMed

52.

Berzin T, Allen S, Taylor L, Rich J, Feller E. Management of hepatitis C in Rhode Island: opportunities for improvement within and beyond the department of corrections. Med Health RI. 2002;85:341–344.

53.

Lo CC, Stephens RC. Drugs and prisoners: treatment needs on entering prison. Am J Drug Alcohol Abuse. May 2000;26(2):229–245.PubMedCrossRef

54.

Pelissier B, Wallace S, O'Neil JA, et al. Federal prison residential drug treatment reduces substance sue and arrests after release. Am J Drug Alcohol Abuse. 2001;27:315–337.PubMedCrossRef

55.

Phillips JA, Nixon SJ, Phillips M, Pfefferbaum B, Briody R. A comparison of substance use between female inmates and female substance misusers in treatment. Alcohol Alcohol. 2000;35:60–65.PubMed

56.

Whitling NJ. New policy on methadone maintenance treatment in prisons established in Alberta. Can HIV AIDS Policy Law Rev. 2003;8:45–47.PubMed

57.

Rich JD, Boutwell AE, Sheild DC, et al. J Urban Health. 2005;82(3):411–419.PubMed

58.

May JP, Williams EL Jr. Acceptability of condom availability in a U.S. jail. AIDS Educ Prev. 2002;14(5 Suppl B):85–91.PubMedCrossRef

59.

Needle exchange ends HIV transmission in Swiss jail. AIDS Policy Law. 1996;11(13):9.

60.

Vlahov D, Anthony JC, Munoz A, et al. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug use: description of methods and characteristics of participants. NIDA Res Monogr. 1991;109:75–100.PubMed

61.

Nelson KE, Galai N, Safaeian M, Strathdee SA, Celentano DD, Vlahov D. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988–1988. Am J Epidemiol. 2002;156:641–653.PubMedCrossRef

62.

Alcabes P, Vlahov D, Anthony JC. Characteristics of intravenous drug users by history of arrest and treatment for drug use. J Nerv Ment Dis. 1992;180:48–54.PubMedCrossRef

63.

Verger P, Rotily M, Prudhomme J, Bird S. High mortality rates among inmates during the year following their discharge from a French prison. J Forensic Sci. 2003;48:614–616.PubMed

64.

Bird SM, Hutchinson SJ. Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996–99. Addiction. 2003;98:185–190.PubMedCrossRef

65.

Seaman SR, Brettle RP, Gore SM. Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ. 1998;316(7129):426–428.PubMed

66.

Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street recruited injection heroin users in the San Francisco Bay Area, 1998–1999. Am J Public Health. 2001;91:1842–1846.PubMedCrossRef

67.

Murray KF, Richardson LP, Morishima C, Owens JW, Gretch DR. Prevalence of hepatitis C virus infection and risk factors in an incarcerated juvenile population: a pilot study. Pediatrics. 2003;111:153–157.PubMedCrossRef

68.

Baillargeon J, Wu H, Kelley MJ, Grady J, Linthicum L, Dunn K. Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system. Public Health. 2003;117:43–48.PubMedCrossRef

69.

van Olphen J, Freudenberg N, Fortin P, Galea S. Community reentry: perceptions of people with substance use problems returning home from New York City jails. J Urban Health. 2006;83(3).

70.

McLean RL, Robarge J, Sherman SG. Release from jail: moment of crisis or window of opportunity for female detainees? J Urban Health. 2006;83(3).

71.

Richie BE, Freudenberg N, Page J. Reintegrating women leaving jail into urban communities: a description of a model program. J Urban Health. 2001;78(2):290–303.PubMed

72.

Rich JD, Holmes L, Salas C, et al. Successful linkage of medical care and community services for HIV-positive offenders being released from prison. J Urban Health. 2001;78(2):279–289.PubMed

73.

Ehrmann T. Community-based organizations and HIV prevention for incarcerated populations: three HIV prevention program models. AIDS Educ Prev. 2002;14(5 Suppl B):75–84.PubMedCrossRef

74.

Inciardi JA. HIV risk reduction and service delivery strategies in criminal justice settings. J Subst Abuse Treat. 1996;13:421–428.PubMedCrossRef

75.

Bauserman RL, Richardson D, Ward M, et al. HIV prevention with jail and prison inmates: Maryland's Prevention Case Management program. AIDS Educ Prev. 2003;15:465–480.PubMedCrossRef

76.

Needels K, James-Burdumy S, Burghardt J. Community case management for former jail inmates: its impacts on rearrest, drug use and HIV risk. J Urban Health. 2005;82(3):420–433.PubMed

77.

Braithwaite R, Stephens TT, Treadwell H, Braithwate K, Conerly R. J Health Care Poor Underserved. 2005;16(4 Suppl B) :130–139.PubMedCrossRef

78.

Stephenson BL, Wohl DA, Golin CE, Tien HC, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep. 2005;120:84–88.PubMed

Title: From Corrections to Communities as an HIV Priority
Authors: David Vlahov, PhD
Sara Putnam
Publication date: 01-05-2006
Publisher: Springer US
Published in: Journal of Urban Health / Issue 3/2006
Print ISSN: 1099-3460
Electronic ISSN: 1468-2869
DOI: https://doi.org/10.1007/s11524-006-9041-x

At a glance: The STEP trials

Springer Medicine

From Corrections to Communities as an HIV Priority

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2006

Community Reentry: Perceptions of People with Substance Use Problems Returning Home from New York City Jails

Housing and Health: Beyond Disciplinary Confinement

Childhood Asthma and Extreme Values of Body Mass Index: The Harlem Children’s Zone Asthma Initiative

Cultural Capital and Self-Rated Health in Low Income Women: Evidence from the Urban Health Study, Beirut, Lebanon

Release from Jail: Moment of Crisis or Window of Opportunity for Female Detainees?

A Method for Observing Physical Activity on Residential Sidewalks and Streets